glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet [Mavyret]
RxNorm concept 2557910, branded drug (sbd). Prescribable name: Mavyret 50 MG / 20 MG per packet Oral Pellet.
- RxCUI
- 2557910
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2557910 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Mavyret (glecaprevir 50 MG / pibrentasvir 20 MG) per packet Oral Pellet
Related concepts
- glecaprevir 50 MG (SCDC, consists of)
- pibrentasvir 20 MG (SCDC, consists of)
- glecaprevir 50 MG / pibrentasvir 20 MG [Mavyret] (SBDC, consists of)
- Oral Pellet (DF, has dose form)
- Mavyret (BN, has ingredient)
- glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2557910 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2557910 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2557910. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.